Maintenance olaparib for patients with newly diagnosed, advanced ovarian cancer and a BRCA mutation: 5-year follow-up from SOLO1 Meeting Abstract


Authors: Bradley, W.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G.; Gourley, C.; Banerjee, S.; Oza, A.; González-Martín, A.; Aghajanian, C.; Cain, T.; Lowe, E.; DiSilvestro, P.
Abstract Title: Maintenance olaparib for patients with newly diagnosed, advanced ovarian cancer and a BRCA mutation: 5-year follow-up from SOLO1
Meeting Title: 2021 Society of Gynecologic Oncology - 52nd Annual Meeting on Women's Cancer
Journal Title: Gynecologic Oncology
Volume: 162
Issue: Suppl. 1
Meeting Dates: 2021 Mar 19-25
Meeting Location: Virtual
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 2021-08-01
Start Page: S25
End Page: S26
Language: English
ACCESSION: WOS:000687070800040
PROVIDER: wos
DOI: 10.1016/S0090-8258(21)00694-6
Notes: Meeting Abstract: 38 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors